Acellular Dermal Matrices Market is Expected to be Flourished by Increasing Number of Surgical Procedures

Acellular dermal matrices are dehydrated sheet or pad formed from mammalian (porcine or bovine) dermis tissue that has undergone a decellularization process to remove cellular debris and DNA, while sustaining a collagen network and tissue-specific proteins. They are used as soft tissue reinforcement materials in various plastic and reconstructive surgeries such as breast reconstruction, abdominal wall reconstruction, and repair of pelvic organ prolapse. Acellular dermal matrices provide strength, biocompatibility, and minimize contraction during surgical site remodeling.

The global acellular dermal matrices market is estimated to be valued at US$ 8.8 Bn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

Increasing Number of Surgical Procedures: Rise in the incidence of soft tissue defects, coupled with increasing number of cancer surgeries and other cosmetic surgeries is driving the growth of acellular dermal matrices market. For instance, according to WHO, breast cancer is the most common cancer in women globally with an estimated 2.3 million new cases diagnosed in 2020. Similarly, colorectal cancer burden is also increasing globally with 1.9 million new cases annually. Further, the demand for breast reconstruction surgeries is increasing owing to rising awareness about post-mastectomy reconstruction. This rising surgical volume is boosting the demand for soft tissue reinforcement materials like acellular dermal matrices during various surgical procedures.

Acellular Dermal Matrices Market is Expected to be Flourished by Increasing Number of Surgical Procedures: As highlighted earlier, the increasing incidence of surgical procedures like cancer surgeries and plastic & reconstructive surgeries is fueling the growth of this market. The soft tissue reconstruction applications of acellular dermal matrices in breast reconstruction, hernia repair, and other surgeries is driving their adoption. Further, growing awareness about cosmetic procedures is also spurring the demand. The clinical efficacy of acellular dermal matrices in tissue repair makes them first choice for surgeons. This rising surgical volume represents abundant business potential and is expected to drive the market during the forecast period.

Segment Analysis

The acellular dermal matrices market can be segmented into animal and human segments. The animal segment dominates the market and accounts for over 70% share owing to wider commercial availability and lower costs compared to human matrices. Animal-derived matrices are obtained from porcine or bovine sources and offer similar structural and functional properties to replace human tissues during reconstructive procedures.

PEST Analysis

Political: Regulations around processing and use of animal and human tissues are well defined to ensure safety and efficacy. However, varying standards across regions impact trade.

Economic: Rising cosmetic surgeries and reconstruction procedures driven by higher disposable incomes favor market growth. However, pricing pressures faced by manufacturers restrict margins.

Social: Acceptance of dermal matrices to replace donor tissues during breast reconstruction after mastectomies is increasing. However, cultural and religious restrictions still impact markets in certain regions.

Technological: Advances in processing techniques help develop acellular matrices with better mechanical strength, tissue integration and reduced immunogenicity. 3D bioprinting also offers opportunities for customized matrix designs.

Key Takeaways

The Global Acellular Dermal Matrices Market Demand is expected to witness high growth. The global Acellular Dermal Matrices Market is estimated to be valued at US$ 8.8 Bn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030.

Regional analysis: North America dominates currently due to extensive coverage of breast reconstruction procedures and technological availability. Asia Pacific is expected to emerge as the fastest growing market riding on rapidly expanding medical tourism industry and growing medical infrastructure.

Key players: Key players operating in the acellular dermal matrices market are Merck & Co., Inc. (Merck Animal Health), Ceva, Zoetis Services LLC, Boehringer Ingelheim International GmbH, Indian Immunologicals Ltd., Bioveta, a.s., and EC21 Inc. Merck & Co., Inc. (Merck Animal Health) and Boehringer Ingelheim International GmbH are the leading players due to their established product portfolios and global distribution networks.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it